Steris
medical device company
STE NYSE
ISIN US8591521005 SEC CIK 1757898 LEI 549300AFNA4MU5267137
Follow Steris
Weekly email: filings, results
Revenue, last quarter
$1.6B
+8.8% vs same quarter last year
Net income
$213.7M
+11.4% vs same quarter last year
EPS, diluted
-
Operating cash flow
$289M
+0.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $5.9B | $782.3M |
| FY25 | $5.5B | $614.6M |
| FY24 | $5.1B | $378.2M |
| FY23 | $4.5B | $107M |
| FY22 | $4.2B | $243.9M |
| FY21 | $3.1B | $397.4M |
| FY20 | $3B | $407.7M |
| FY19 | $2.8B | $303.7M |
| FY18 | $2.6B | $290.9M |
| FY17 | $2.6B | $110M |
| FY16 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 44.2% | 18.6% | 13.2% |
| FY25 | 44% | 15.9% | 11.3% |
| FY24 | 43.2% | 16.3% | 7.4% |
| FY23 | 43.7% | 17.4% | 2.4% |
| FY22 | 44.6% | 11.3% | 5.8% |
| FY21 | 43.2% | 17.6% | 12.8% |
| FY20 | 43.6% | 17.7% | 13.5% |
| FY19 | 42.2% | 14.8% | 10.9% |
| FY18 | 41.7% | 15.3% | 11.1% |
| FY17 | 39.3% | 8.7% | 4.2% |
| FY16 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | $972.4M |
| FY25 | $778M |
| FY24 | $613M |
| FY23 | $395M |
| FY22 | $397.2M |
| FY21 | $450.4M |
| FY20 | $376M |
| FY19 | $349.8M |
| FY18 | $292.2M |
| FY17 | $251.2M |
| FY16 | - |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY26 | $241.8M | $235.5M |
| FY25 | $219.9M | $211.3M |
| FY24 | $200.6M | $11.8M |
| FY23 | $183.5M | $308.6M |
| FY22 | $163.2M | $55.8M |
| FY21 | $133.8M | $14.6M |
| FY20 | $123M | $51.2M |
| FY19 | $112.5M | $81.5M |
| FY18 | $102.9M | $65.5M |
| FY17 | $93.2M | $97.5M |
| FY16 | - | - |
- Steris
- Healthcare median
Show the numbers
| Year | Steris | Healthcare median |
|---|---|---|
| FY26 | 13.2% | −11.1% |
| FY25 | 11.3% | −30.6% |
| FY24 | 7.4% | −47% |
| FY23 | 2.4% | −58% |
| FY22 | 5.8% | −80.4% |
| FY21 | 12.8% | −71.9% |
| FY20 | 13.5% | −62.2% |
| FY19 | 10.9% | −46.3% |
| FY18 | 11.1% | −49.6% |
| FY17 | 4.2% | −45.9% |
| FY16 | - | −36% |